12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several healthcare stocks experienced significant movements. Moleculin Biotech, Evoke Pharma, TC BioPharm, CNS Pharma, Atreca, and ASLAN Pharma were among the gainers, with increases ranging from 5.94% to 8.7%. Conversely, Savara, MyMD Pharmaceuticals, Alector, Enliven Therapeutics, Estrella Immunopharma, and Trevena were the losers, with declines between 4.97% and 11.9%. The market capitalizations of these companies vary, with some below $10 million and others exceeding $500 million.
January 16, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Alector's stock fell 8.38% to $7.0, with a market value of $588.9 million.
Alector's significant after-market drop suggests potential concerns among investors, which may result in a short-term negative trend.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Savara's stock decreased by 11.9% to $3.75, with a market cap of $507.5 million.
The notable after-market decline in SVRA's stock price could indicate negative investor sentiment, potentially leading to further short-term downward pressure.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Evoke Pharma's stock increased by 7.27% to $0.92, with a market cap of $3.0 million.
The after-market rise in EVOK's stock price indicates a positive reaction from investors, potentially leading to further short-term gains.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Moleculin Biotech's stock rose by 8.7% to $0.72, with a market cap of $23.9 million.
The significant after-market increase in MBRX's stock price suggests positive investor sentiment, which could lead to a short-term continuation of this upward trend.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80